Allspring Global Investments’s Anavex Life Sciences AVXL Stock Holding History

Allspring Global Investments’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,152	Closed	-$12.2K	–	1808
2024 Q3	$12.2K	Hold	2,152	–	–	﹤0.01%	2062
2024 Q2	$9.08K	Buy	+2,152	New	+$8.7K	﹤0.01%	2196
2023 Q4	–	Sell	-3,061	Closed	-$20K	–	2258
2023 Q3	$20K	Buy	3,061 +996	+48%	+$7.93K	﹤0.01%	2511
2023 Q2	$16.8K	Buy	+2,065	New	+$17.7K	﹤0.01%	2487
2022 Q3	–	Sell	-1,911	Closed	-$19K	–	2877
2022 Q2	$19K	Sell	1,911 -15,836	-89%	-$150K	﹤0.01%	2493
2022 Q1	$218K	Buy	17,747 +211	+1%	+$2.6K	﹤0.01%	2543
2021 Q4	$304K	Buy	+17,536	New	+$333K	﹤0.01%	2504

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Allspring Global Investments's AVXL Position: Q4 2024 in Review

Allspring Global Investments sold out of Anavex Life Sciences (AVXL) in Q4 2024, closing a stake of 2,152 shares — an estimated $12.2K sold.

Allspring Global Investments first reported a position in AVXL in Q4 2021 and held it in 7 quarters. The position peaked at $304K in Q4 2021. 168 funds tracked by Wall St. Rank hold AVXL as of Q4 2024.

Allspring Global Investments reported no remaining Anavex Life Sciences position as of Q4 2024 after selling out during the quarter.
Allspring Global Investments sold 2,152 Anavex Life Sciences shares in Q4 2024, an estimated $12.2K.
Allspring Global Investments first reported a position in Anavex Life Sciences in Q4 2021 and held it in 7 quarters.
Allspring Global Investments's Anavex Life Sciences position peaked at $304K in Q4 2021.
168 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.